Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

OMGA

Omega Therapeutics Inc

May 06 • 04:00PM ET

2.28

Dollar change -0.30
Percentage change -11.63	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWO VTWO IWC VTWG AVSC HAPS BTEC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.81	Insider Own	62.98%	Shs Outstand	55.14M	Perf Week	-0.44%
Market Cap	125.76M	Forward P/E	-	EPS next Y	-1.17	Insider Trans	0.00%	Shs Float	20.42M	Perf Month	-22.71%
Income	-97.43M	PEG	-	EPS next Q	-0.31	Inst Own	29.86%	Short Float	21.70%	Perf Quarter	-33.14%
Sales	3.10M	P/S	40.57	EPS this Y	34.76%	Inst Trans	0.24%	Short Ratio	11.10	Perf Half Y	26.67%
Book/sh	1.05	P/B	2.17	EPS next Y	0.54%	ROA	-55.62%	Short Interest	4.43M	Perf Year	-71.71%
Cash/sh	1.33	P/C	1.71	EPS next 5Y	-	ROE	-118.82%	52W Range	1.30 - 10.09	Perf YTD	-24.25%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-48.08%	ROI	-56.93%	52W High	-77.40%	Beta	2.01
Dividend TTM	-	Quick Ratio	3.35	Sales past 5Y	347.21%	Gross Margin	-118.77%	52W Low	75.38%	ATR (14)	0.24
Dividend Ex-Date	-	Current Ratio	3.35	EPS Y/Y TTM	15.73%	Oper. Margin	-3239.42%	RSI (14)	38.28	Volatility	11.54% 7.97%
Employees	94	Debt/Eq	2.21	Sales Y/Y TTM	49.23%	Profit Margin	-3147.92%	Recom	1.00	Target Price	11.00
Option/Short	Yes / Yes	LT Debt/Eq	1.95	EPS Q/Q	43.04%	Payout	-	Rel Volume	1.45	Prev Close	2.58
Sales Surprise	102.70%	EPS Surprise	-8.14%	Sales Q/Q	34.56%	Earnings	May 06 BMO	Avg Volume	399.33K	Price	2.28
SMA20	-10.72%	SMA50	-29.38%	SMA200	-26.52%	Trades		Volume	578,510	Change	-11.63%

Date	Action	Analyst	Rating Change	Price Target Change
May-25-23	Resumed	Jefferies	Buy	$18 → $15
Dec-08-22	Initiated	H.C. Wainwright	Buy	$11
Sep-23-22	Initiated	Chardan Capital Markets	Buy	$12

Today 02:52PM	OMGA Stock Earnings: Omega Therapeutics Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace) -11.63%
08:10AM	Omega Therapeutics, Inc. (OMGA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:00AM	Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress (GlobeNewswire)
Apr-25-24 10:02AM	Omega Therapeutics, Inc. (OMGA) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Apr-23-24 07:00AM	Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting (GlobeNewswire)
09:55AM	Loading…
Apr-17-24 09:55AM	Omega Therapeutics (OMGA) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now (Zacks) +6.02%
Apr-09-24 07:00AM	Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic Control (GlobeNewswire)
Apr-08-24 08:00AM	Flagship Appoints Amy O'Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences (PR Newswire)
Apr-03-24 12:00PM	Omega Therapeutics (OMGA) Upgraded to Buy: Here's What You Should Know (Zacks)
Mar-28-24 11:54PM	OMGA Stock Earnings: Omega Therapeutics Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace)
10:25AM	Omega Therapeutics, Inc. (OMGA) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
09:15AM	Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update (GlobeNewswire)
Mar-19-24 08:30AM	Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024 (PR Newswire)
Mar-06-24 07:00AM	Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024 (GlobeNewswire) +5.47%
Jan-09-24 11:01PM	The 3 Best Biotech Stocks to Buy in January 2024 (InvestorPlace)
08:44AM	Loading…
08:44AM	DEAN BANKS APPOINTED CEO OF INDIGO AG AND CEO-PARTNER OF FLAGSHIP PIONEERING (PR Newswire)
Jan-08-24 06:30AM	Flagship Pioneering Debuts Enabling Technologies Initiative (PR Newswire)
06:30AM	Flagship Pioneering and Samsung Announce Collaboration to Advance Groundbreaking Technologies in Translational Science and Medicine (PR Newswire)
Jan-05-24 12:55PM	Omega (OMGA) Up 95% on Obesity Drug Deal With Novo Nordisk (Zacks) -17.40%
Jan-04-24 06:08PM	Why Novo Nordisk Stock Crushed the Market Today (Motley Fool) +94.69%
04:01PM	Novo Nordisk, The Weight-Loss Kingpin, Breaks Out After Inking Two New Deals In Obesity (Investor's Business Daily)
10:02AM	Novo Nordisk enters research partnerships with biotech firms (Yahoo Finance Video)
08:20AM	Why Is Omega Therapeutics (OMGA) Stock Up 111% Today? (InvestorPlace)
06:00AM	Wegovy maker Novo Nordisk signs research partnerships with U.S. biotech firms (Reuters)
05:59AM	Novo Nordisk enters into research collaborations with Omega Therapeutics and Cellarity on novel treatment approaches for cardiometabolic diseases (GlobeNewswire)
Jan-02-24 04:05PM	Omega Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-04-23 04:00PM	Omega Therapeutics to Participate in the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference (GlobeNewswire)
Nov-27-23 07:01PM	Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science Leaders (PR Newswire)
Nov-21-23 06:00AM	Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics (PR Newswire)
Nov-20-23 04:00PM	Omega Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference (GlobeNewswire) -6.54%
07:00AM	Loading…
Nov-13-23 07:00AM	Omega Therapeutics Showcases Bidirectional and Multiplexed Epigenomic Control of Gene Expression in Preclinical Models of Liver Inflammation and Fibrosis (GlobeNewswire)
Nov-09-23 07:00AM	Omega Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress (GlobeNewswire) -5.06%
Nov-07-23 04:00PM	Omega Therapeutics to Participate in The Jefferies London Healthcare Conference (GlobeNewswire)
Nov-01-23 10:30AM	Flagship Pioneering Launches Pioneering Intelligence (PR Newswire)
Oct-31-23 07:00AM	Omega Therapeutics Presents New Preclinical Data Demonstrating Pre-Transcriptional Modulation of Multiple CXCL Genes by a Single Epigenomic Controller (GlobeNewswire) -7.43%
Oct-19-23 10:30AM	Flagship Pioneering Announces the Merger of Two Leading Programmable Medicine Platforms to Form Sail Biomedicines (PR Newswire) -11.63%
Oct-16-23 07:00AM	Omega Therapeutics Presents New Preclinical Data Supporting the Potential of OTX-2101 in Combination Settings for Treatment of NSCLC (GlobeNewswire)
Oct-11-23 04:00PM	Omega Therapeutics Announces Two Poster Presentations on Liver Inflammation and Fibrosis at AASLD's The Liver Meeting 2023 (GlobeNewswire) -12.93%
Oct-04-23 04:00PM	Omega Therapeutics to Present New Preclinical Data on OTX-2101 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (GlobeNewswire)
Oct-02-23 07:00AM	Flagship Pioneering Appoints John Lepore as CEO-Partner and CEO of ProFound Therapeutics (PR Newswire) -12.09%
Sep-27-23 08:31AM	Flagship Pioneering Named to Fortune's 2023 'Change the World' List (PR Newswire)
Sep-26-23 07:00AM	Omega Therapeutics Announces Promising Preliminary Clinical Data for OTX-2002 from Ongoing MYCHELANGELO I Trial (GlobeNewswire) -23.17%
Sep-25-23 04:00PM	Omega Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data for OTX-2002 from Ongoing MYCHELANGELO I Trial on September 26 (GlobeNewswire)
Sep-21-23 04:00PM	Omega Therapeutics to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
Sep-11-23 06:30AM	Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer (PR Newswire)
Aug-29-23 07:00AM	Omega Therapeutics Announces Updates to its Board of Directors (GlobeNewswire) +8.29%
Aug-05-23 08:05AM	Omega Therapeutics Second Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.)
Aug-03-23 05:15PM	Omega Therapeutics, Inc. (OMGA) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:00PM	Omega Therapeutics Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress (GlobeNewswire)
Jul-20-23 07:39AM	Recursion (RXRX) Stock Surges 191% in 3 Months: Here's Why (Zacks) +8.85%
Jul-18-23 09:43AM	Corcept's (CORT) Early-Stage Study on NASH Reveals Positive Data (Zacks)
Jul-12-23 07:00AM	Omega Therapeutics Appoints Chris Schade to its Board of Directors (GlobeNewswire) +12.25%
Jul-03-23 11:20AM	Baudax Bio (BXRX) Up 125% on Acquiring TeraImmune (Zacks) -14.11%
Jun-22-23 09:18AM	Alderya (ALDX) Stock Declines on Getting CRL for PVRL Candidate (Zacks)
Jun-14-23 11:48AM	Recursion (RXRX) Up on Completing REC-994 Study Enrollment (Zacks)
Jun-08-23 11:49AM	Timber (TMBR) Surges on Carcinogenicity Waiver for TMB-001 (Zacks)
Jun-06-23 12:13PM	Bellerophon (BLPH) Down 87% as Lung Disease Candidate Fails (Zacks)
Jun-01-23 07:00AM	Omega Therapeutics to Participate in Two Upcoming Investor Conferences (GlobeNewswire) -5.14%
May-31-23 08:30AM	Ashvattha Therapeutics Expands Leadership Team with Appointment of Paul E. Cayer as Chief Financial Officer and Mahesh Karande to the Board of Directors (GlobeNewswire)
07:00AM	Omega Therapeutics Presents New Preclinical Data Demonstrating the Potential of Omega Epigenomic Controllers to Synergize with Immunotherapies at the ASCO 2023 Annual Meeting (GlobeNewswire)
May-25-23 09:55AM	Wall Street Analysts See a 59.64% Upside in Omega Therapeutics, Inc. (OMGA): Can the Stock Really Move This High? (Zacks) -9.24%
May-16-23 06:00AM	Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry (PR Newswire)
May-10-23 07:34AM	Investors in Omega Therapeutics (NASDAQ:OMGA) have seen impressive returns of 177% over the past year (Simply Wall St.) -5.46%
May-09-23 09:55AM	Wall Street Analysts Think Omega Therapeutics, Inc. (OMGA) Could Surge 48.23%: Read This Before Placing a Bet (Zacks)
May-04-23 08:35AM	Omega Therapeutics, Inc. (OMGA) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
07:00AM	Omega Therapeutics Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress (GlobeNewswire)
Apr-27-23 07:00AM	Omega Therapeutics to Present New Preclinical Data at the American Society of Clinical Oncology 2023 Annual Meeting (GlobeNewswire) +9.74%
Apr-13-23 06:33AM	Private equity firms account for 53% of Omega Therapeutics, Inc.'s (NASDAQ:OMGA) ownership, while institutions account for 32% (Simply Wall St.) +6.44%
Apr-06-23 04:01AM	Omega Therapeutics, Inc. (OMGA) Surges 19.6%: Is This an Indication of Further Gains? (Zacks) +7.79%
Mar-30-23 07:00AM	Omega Therapeutics Announces Clinical Supply Agreement to Evaluate the Combination of OTX-2002 and Atezolizumab in Hepatocellular Carcinoma (GlobeNewswire)
Mar-17-23 03:35AM	Omega Therapeutics, Inc. (OMGA) Moves 15.2% Higher: Will This Strength Last? (Zacks) +25.22%
Mar-03-23 05:01AM	When Can We Expect A Profit From Omega Therapeutics, Inc. (NASDAQ:OMGA)? (Simply Wall St.)
Mar-01-23 08:35AM	Omega Therapeutics, Inc. (OMGA) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:00AM	Omega Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Feb-23-23 07:00AM	Omega Therapeutics Announces $40 Million Registered Direct Offering of Common Stock (GlobeNewswire)
Feb-10-23 04:11AM	Omega Therapeutics, Inc. (OMGA) Surges 37.2%: Is This an Indication of Further Gains? (Zacks) -10.08%
Jan-17-23 07:00AM	Omega Therapeutics to Present Trial-in-Progress Poster for Phase 1/2 MYCHELANGELO I Study at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (GlobeNewswire) -12.60%
Dec-08-22 01:24PM	Omega Therapeutics Could Offer 'Intriguing' Liver Cancer Drug, Analyst Says (Benzinga)
Nov-28-22 09:55AM	Wall Street Analysts Think Omega Therapeutics, Inc. (OMGA) Could Surge 136%: Read This Before Placing a Bet (Zacks)
Nov-17-22 07:00AM	Omega Therapeutics to Participate in the Piper Sandler 34th Annual Healthcare Conference (PR Newswire)
Nov-15-22 07:00AM	Omega Therapeutics Named One of BioSpace's 2023 Best Places to Work (PR Newswire)
Nov-11-22 09:55AM	Wall Street Analysts Believe Omega Therapeutics, Inc. (OMGA) Could Rally 229%: Here's is How to Trade (Zacks) +16.57%
Nov-10-22 05:57AM	Shareholders in Omega Therapeutics (NASDAQ:OMGA) have lost 79%, as stock drops 13% this past week (Simply Wall St.) +9.15%
Nov-08-22 07:00AM	Omega Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights (PR Newswire)
Nov-03-22 07:00AM	Omega Therapeutics to Participate in the Jefferies London Healthcare Conference (PR Newswire)
Nov-02-22 07:00AM	Omega Therapeutics Receives Orphan Drug Designation for OTX-2002 for the Treatment of Hepatocellular Carcinoma (PR Newswire)
Oct-27-22 07:00AM	Omega Therapeutics Announces First Patient Dosed in Landmark MYCHELANGELO I Trial of OTX-2002 in Hepatocellular Carcinoma and Other Solid Tumor Types Associated with the MYC Oncogene (PR Newswire) -5.05%
Oct-12-22 07:00AM	Omega Therapeutics Unveils New Epigenomic Controller Development Candidate Targeting MYC-Driven Non-Small Cell Lung Cancer (PR Newswire)
Sep-26-22 07:00AM	Omega Therapeutics to Participate in Two Upcoming Investor Conferences (PR Newswire) -5.41%
Sep-06-22 07:00AM	Omega Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference (PR Newswire) +7.69%
Sep-01-22 07:00AM	Omega Therapeutics Announces Appointment of Rainer Boehm to its Board of Directors (PR Newswire) +9.84%
Aug-04-22 07:00AM	Omega Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress (PR Newswire) +5.56%
Aug-03-22 07:00AM	Omega Therapeutics to Participate in the 2022 Wedbush PacGrow Healthcare Conference (PR Newswire)
Jul-14-22 04:05PM	Omega Therapeutics Announces FDA Clearance of IND Application for OTX-2002, First Omega Epigenomic Controller, for MYC Driven Hepatocellular Carcinoma (PR Newswire)
Jul-11-22 11:03AM	Omega Therapeutics, Inc. (NASDAQ:OMGA) is up 28%, but insiders still continue to see a loss of US$692k on their US$952k investment (Simply Wall St.) -5.17%
Jun-30-22 11:32AM	Omega Therapeutics Touts Encouraging Preclinical Data In Liver Cancer Animal Models (Benzinga) -10.80%
07:00AM	Omega Therapeutics Presents New Preclinical Data Supporting the First Epigenomic Controller, OTX-2002, as a Potential Therapeutic Approach in Hepatocellular Carcinoma at the ESMO 2022 World Congress on Gastrointestinal Cancer (PR Newswire)
Jun-23-22 07:00AM	Omega Therapeutics to Present New Preclinical Data for the First Epigenomic Controller, OTX-2002, for Hepatocellular Carcinoma at the European Society of Medical Oncology's 2022 World Congress on Gastrointestinal Cancer (PR Newswire) +16.40%
Jun-15-22 02:58PM	Encompass Health (EHC) Plans to Distribute Enhabit Shares (Zacks)
07:00AM	Omega Therapeutics Announces Submission of Investigational New Drug Application for OTX-2002, an Omega Epigenomic Controller, for MYC Driven Hepatocellular Carcinoma (PR Newswire)

Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It offers its product under the OMEGA platform. The company was founded by Noubar B. Afeyan and David Berry on July 13, 2016 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Young Richard A	Director	Jun 02 '23	Sale	8.00	5,000	40,000	739,118	Jun 05 04:15 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

OMGA

Omega Therapeutics Inc

Upgrade your FINVIZ experience